crt was significantly reduced at 1 month ( p=0.031 ) after the surgery , and the reduction increased with time ( p=0.007 at the final visit ) . with the reduction in crt
described herein , we retrospectively investigated the anatomic and functional outcomes of eyes treated with pars plana vitrectomy combined with internal limiting membrane peeling for recurrent me due to brvo , in spite of anti - vegf treatment .
now , anti - vegf treatment is generally accepted as the first choice for me associated with brvo.79,24 indeed , the effect of anti - vegf treatment is rapid and remarkable . in the bravo study , the mean improvement in va was 16.6 and 18.3 letters with 6 monthly injections of ranibizumab ( 0.3 mg and 0.5 mg , respectively).10 however , most eyes need to be treated repeatedly . in the horizon trial ,
in the retrospective study reported herein , pars plana vitrectomy combined with internal limiting membrane peeling showed efficacy for recurrent me associated with brvo after anti - vegf treatment .
for this retrospective study , we reviewed the medical records of 24 eyes of 24 consecutive patients who underwent pars plana vitrectomy combined with internal limiting membrane peeling for recurrent me due to brvo after anti - vegf treatment at kagawa university hospital from october 2009 through december 2012 .